Point72 Asset Management
SPPI

Point72 Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Point72 Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-550,000
Closed -$8.85M – 1236
2018
Q1 		$8.85M Sell
550,000
-250,000
-31% -$4.95M 0.04% 451
2017
Q4 		$15.2M Buy
+800,000
New +$14.5M 0.07% 365

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management's SPPI Position: Q4 2020 in Review

Point72 Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2020, closing a stake of 94,825 shares — an estimated $387K sold.

Point72 Asset Management first reported a position in SPPI in Q2 2018 and held it in 4 quarters. The position peaked at $4.72M in Q4 2018. 161 funds tracked by Wall St. Rank hold SPPI as of Q4 2020.

  • Point72 Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Point72 Asset Management sold 94,825 Spectrum Pharmaceuticals Inc shares in Q4 2020, an estimated $387K.
  • Point72 Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 4 quarters.
  • Point72 Asset Management's Spectrum Pharmaceuticals Inc position peaked at $4.72M in Q4 2018.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2020.

Based on Point72 Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.